ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Every earnings call announcement on NSE and BSE that our alert engine sent, newest first. Each one has its own page with the summary, the key figures and the original filing.
Time
9,412 announcements with these filters
Vijaya Diagnostic reported a landmark FY26 with revenues crossing ₹800cr and Q4 revenue growth of 26.6%. The company is focusing on network expansion and high-end diagnostics like Genomics.
Kriti Industries reported Q4 FY26 revenue of ₹142cr (3% YoY) with sharp EBITDA margin improvement to 12.91%. Full-year FY26 revenue declined 19% to ₹587cr.
Hindalco's Q3FY26 consolidated EBITDA rose 6% YoY to ₹8,762 crores. Reported PAT fell 45% due to Oswego plant fire impacts, but adjusted PAT grew 8% YoY.
CreditAccess Grameen reported Q4 FY26 PAT of INR 340 Cr (up 6x YoY) with 14% AUM growth. The company is pivoting towards a rural-focused inclusive finance platform via 'Project Shakti'.
Sagility reported Q1 FY26 revenue of ₹15,389M (up 25.8% YoY) and adjusted EBITDA of ₹3,687M, maintaining 24% margins despite seasonality.
MTAR achieved record FY26 revenue of ₹876.2 Cr and PAT of ₹94.0 Cr, driven by strong clean energy orders. Focused on expanding into aerospace structural assemblies and new oil & gas facilities.
Maxvolt Energy's H2 FY26 presentation highlights its transition into a circular lithium ecosystem. Key 3-year CAGR metrics show exponential growth: Revenue 179%, EBITDA 302%, and PAT 344%.
Marico delivered multi-year high consolidated revenue growth in Q4FY26. Management is pivoting toward premium personal care and foods to reduce commodity-linked business share.
Sundram Fasteners reported FY26 revenue of ₹5,612 cr, a 7% growth. PAT (after MTM) reached a record ₹577 cr.
Tata Consumer Products crossed INR 20,000 cr revenue in FY26. Management focused on premiumization, innovation (4.5% of sales), and scaling growth businesses like Sampann and RTD.
Dabur Q4 FY26 results show consolidated revenue growth of 7.3%, driven by double-digit performance in HPC and Home Care, despite headwinds in Middle East.
KEI reports robust Q4 FY26 results with 19.3% revenue growth and margin expansion to 12.2%. Strategy emphasizes scaling B2C dealer networks and high-margin EHV cable segments.
KP Energy reports strong execution in its wind EPC segment, though margins remain sensitive to project-specific timelines and land acquisition hurdles.
Vardhman Textiles reported Q4 FY26 earnings with a focus on improving yarn spreads and capacity utilization following the removal of US tariffs.
eMudhra delivered strong FY26 performance with 35.1% revenue growth and 26.2% PAT growth, driven by expansion in Enterprise Solutions and international markets.
Stylam maintains optimism despite persistent delays in its new Greenfield plant, now pushed to June-July 2025. Management relies on Akyu strategic partnership to drive high-margin exports and acrylic segment growth.
Ceigall India reported strong FY26 performance with diversified order inflows in renewables and roads. Management maintains a conservative growth stance while expanding international presence.
Vimta Labs reported Q4 FY26 revenue of ₹1,120M (+16.6% YoY) and FY26 revenue of ₹4,163M (+19.5% YoY). Strategy focuses on core pharma/food testing and entry into biologics.
Meesho Q4 FY26 earnings call highlighting 170bps sequential contribution margin improvement and a pivot toward higher prepaid order mix and ad-revenue monetization.
JSW Infrastructure (JSW Infra) delivered resilient Q4 FY26 results with annual revenue of ₹5,361cr (+20% YoY) and EBITDA of ₹2,604cr (+15%). Strategy focuses on port capacity expansion and logistics integration.
Privi delivered strong FY26 performance with 22% revenue growth and 25%+ margins. Management is pivoting from a '5k revenue' goal to a more aggressive long-term trajectory via high-value specialty molecules and backward integration.
Raymond Limited delivered Q4 total income of ₹613cr and FY26 total income of ₹2,312cr (up 10% YoY). Company maintains a debt-free status with ₹68cr net cash.
Kansai Nerolac reports Q4 FY26 consolidated revenue growth of 7.5% and PBDIT up 30.6%. Strategy focuses on premiumization, new growth drivers, and industrial segment expansion.
Management is navigating a ₹230cr cost overrun on the PLA project by diversifying into gypsum boards and raising ₹450cr in equity to maintain liquidity and credit ratings.
Blue Star reported Q4FY26 revenue of ₹4,072 Cr (up 1.3%) and record EBITDA of ₹326.3 Cr (8% margin). Full-year FY26 revenue grew 3.6% to ₹12,402 Cr.
GRSE reports record revenue and profit for FY26, driven by an aggressive warship execution schedule and successful delivery of eight vessels.
PPL reported strong FY26 performance with Revenue at ₹218,263 Mn and PAT at ₹10,008 Mn. Strategy focuses on backward integration and expanding NPK/DAP capacity to 5.0 MMTPA by FY29.
PNB reported record net profit of ₹5,225cr for Q4 FY26, driven by improved asset quality (GNPA at 2.95%) and credit growth of 12.7%.
Anthem Biosciences delivered a high-growth Q1 FY26, leveraging its commercialized molecule portfolio and strong cash position. Management is balancing aggressive capacity expansion with optimistic 20% long-term growth aspirations despite near-term lumpiness.
Neuland Laboratories' March 2026 API Product List showcases a robust portfolio across diverse therapeutic segments including anticoagulants, antipsychotics, and peptides.